Ligand validation:5U26

MMV: 3-(2-{3-[(2,4-diamino-6-ethylpyrimidin-5-yl)oxy]propoxy}phenyl)propanoic acid

MMV is a Ligand Of Interest in 5U26 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5U26_MMV_A_201	91%	18%	0.08	0.967	1.71	1.79	2	6	0	0	100%	1
5UJF_MMV_A_205	70%	14%	0.149	0.968	1.9	1.92	2	6	1	0	100%	1
7K6C_MMV_C_202	98%	43%	0.051	0.971	1.17	1.05	2	3	0	0	100%	1
7K62_MMV_A_202	78%	34%	0.1	0.943	1.21	1.38	2	6	0	0	100%	1
4DDR_MMV_A_202	76%	5%	0.113	0.948	2.78	2.66	12	12	0	0	100%	1
7TJ3_MMV_A_202	69%	58%	0.117	0.932	0.51	1.1	-	2	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.